RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+9.33%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$5.05B
AUM Growth
+$5.05B
(+10%)
Cap. Flow
+$474M
Cap. Flow
% of AUM
9.39%
Top 10 Holdings %
Top 10 Hldgs %
27.44%
Holding
165
New
13
Increased
67
Reduced
10
Closed
9
Top Buys
| 1 |
Agilon Health
AGL
|
$284M |
| 2 |
LENZ
LENZ Therapeutics
LENZ
|
$66.1M |
| 3 |
VERV
Verve Therapeutics
VERV
|
$58M |
| 4 |
Lifestance Health
LFST
|
$41.8M |
| 5 |
NeueHealth
NEUE
|
$40.8M |
Top Sells
| 1 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$100M |
| 2 |
AstraZeneca
AZN
|
$32.3M |
| 3 |
Inspire Medical Systems
INSP
|
$20.7M |
| 4 |
Atea Pharmaceuticals
AVIR
|
$19.4M |
| 5 |
UnitedHealth
UNH
|
$14M |
Sector Composition
| 1 | Healthcare | 94.39% |
| 2 | Consumer Staples | 1.63% |
| 3 | Industrials | 0.72% |
| 4 | Financials | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRRA
76
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $19.8M | 0.39% | 1,018,658 +1,300 | +0.1% | +$25.3K |
|
77
DexCom
DXCM
$29.5B
| $19.5M | 0.38% | 45,600 +30,600 | +204% | +$13.1M |
|
78
InnovAge Holding
INNV
$517M
| $19.2M | 0.38% | 902,500 +427,500 | +90% | +$9.11M |
|
|
TBIO
79
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $19.1M | 0.38% | 693,266 +43,366 | +7% | +$1.19M |
|
|
AMRN
80
Amarin Corp
AMRN
$311M
| $18.9M | 0.37% | 4,320,000 +125,000 | +3% | +$548K |
|
81
Biomea Fusion
BMEA
$116M
| $18.2M | 0.36% | +1,165,582 | New | +$18.2M |
|
|
SPRB
82
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| $18M | 0.36% | 1,605,001 +25,700 | +2% | +$288K |
|
83
Rocket Pharmaceuticals
RCKT
$354M
| $17.9M | 0.35% | 403,270 +200 | +0% | +$8.86K |
|
84
Kura Oncology
KURA
$686M
| $17M | 0.34% | 816,800 +106,765 | +15% | +$2.23M |
|
|
85
Atea Pharmaceuticals
AVIR
$267M
| $17M | 0.34% | 791,133 -903,770 | -53% | -$19.4M |
|
86
Dynavax Technologies
DVAX
$1.19B
| $16.5M | 0.33% | 1,679,921 +21,401 | +1% | +$211K |
|
87
Relay Therapeutics
RLAY
$619M
| $16.5M | 0.33% | 450,258 +198,131 | +79% | +$7.25M |
|
88
Nkarta
NKTX
$151M
| $15.8M | 0.31% | 497,948 +6,100 | +1% | +$193K |
|
|
CHMA
89
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $15.4M | 0.3% | 3,258,144 +1,083,561 | +50% | +$5.13M |
|
|
RXDX
90
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $14.6M | 0.29% | 596,096 +21,238 | +4% | +$522K |
|
|
OLK
91
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $14.6M | 0.29% | 425,000 +25,000 | +6% | +$861K |
|
92
Applied Therapeutics
APLT
$71M
| $14.6M | 0.29% | 701,680 | – | – |
|
|
MREO
93
Mereo BioPharma
MREO
$272M
| $14.4M | 0.28% | 4,542,769 +47,900 | +1% | +$152K |
|
94
ESSA Pharma
EPIX
$11.4M
| $14.4M | 0.28% | 503,035 | – | – |
|
|
INZY
95
DELISTED
Inozyme Pharma
INZY
| $14.3M | 0.28% | 840,272 +12,372 | +1% | +$211K |
|
96
AnaptysBio
ANAB
$569M
| $13.9M | 0.27% | 535,232 | – | – |
|
|
GMDA
97
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $13.5M | 0.27% | 2,107,000 +6,700 | +0.3% | +$42.9K |
|
98
Spero Therapeutics
SPRO
$116M
| $13.5M | 0.27% | 965,928 | – | – |
|
99
Akero Therapeutics
AKRO
$3.74B
| $13.1M | 0.26% | 528,601 +7,430 | +1% | +$184K |
|
100
Legend Biotech
LEGN
$6.41B
| $12.8M | 0.25% | 312,618 | – | – |
|